Products Categories
| CAS No.: | 96829-58-2 |
|---|---|
| Name: | Orlistat |
| Article Data: | 51 |
| Cas Database | |
| Molecular Structure: | |
|
|
|
| Formula: | C29H53NO5 |
| Molecular Weight: | 495.744 |
| Synonyms: | (-)-Tetrahydrolipstatin;Alli;N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone;Orlistat [USAN:INN];Ro 18-0647/002;Orlipastatum [INN-Latin];L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-;[(2S)-1-[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]tridecan-2-yl] 2-formamido-4-methyl-pentanoate;Tetrahydrolipstatin;Xenical;L-Leucine,N-formyl-,(1S)-1-[[(2S,3S)-3- hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;Taizhou hikong chemical sell orlistat; |
| EINECS: | 639-755-1 |
| Density: | 0.976 g/cm3 |
| Melting Point: | <50 °C |
| Boiling Point: | 615.9 °C at 760 mmHg |
| Flash Point: | 326.3 °C |
| Solubility: | DMSO: 19 mg/mL in water |
| Appearance: | off-white solid |
| PSA: | 81.70000 |
| LogP: | 7.90870 |
- 96829-59-3L-Leucine, N-formyl-,(1S,3Z,6Z)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-3,6-dodecadien-1-ylester
- 968-29-6Benzenepropanamide,N-(4-nitrophenyl)-b-oxo-
- 96829-60-61,7-Ethenocycloprop[c]isobenzofuran,4-[(1R)-1,5-dimethyl-4-hexenyl]-1,1a,3,3a,4,5,6,7-octahydro-7-methyl-,(1R,1aR,3aR,4R,7R,7aR)- (9CI)
- 96-83-3Benzenepropanoic acid,3-amino-a-ethyl-2,4,6-triiodo-
- 96835-17-52H-Pyran-4-carboxylicacid, tetrahydro-, ethyl ester
- 96841-04-25-AMINO-4-CHLORO-3-METHYLISOTHIAZOLE
- 96846-67-21,1-Dimethyl-5-methyleneheptyl butyrate
- 96846-71-8Dipotassium 4,4-bis((4-methoxyphenyl)azo)stilbene-2,2-disulphonate
- 96847-55-1Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1R,2S)-
- 96849-38-6L-Isoleucinamide,L-histidyl-L-alanyl-L-a-aspartylglycyl-L-valyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-aspartyl-L-tyrosyl-L-seryl-L-arginyl-L-leucyl-L-leucylglycyl-L-glutaminyl-L-isoleucyl-L-seryl-L-alanyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-a-glutamyl-L-seryl-L-leucyl- (9CI)
- 56-40-6Glycine
- 4468-48-8Benzeneacetonitrile, a-acetyl-
- 75-09-2Dichloromethane
- 1333-86-4Carbon Black
- 64-19-7Acetic acid glacial
- 171599-83-0Sildenafil citrate
- 120-51-4Benzyl benzoate
- 9004-32-4Carboxymethyl cellulose
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Chemistry
Molecular Structure:
Molecular Formula: C29H53NO5
Molecular Weight: 495.73
CAS NO: 96829-58-2
H bond acceptors: 6
H bond donors: 1
Freely Rotating Bonds: 23
Polar Surface Area: 72.91 Å2
Index of Refraction: 1.469
Molar Refractivity: 141.57 cm3
Molar Volume: 507.5 cm3
Surface Tension: 35.6 dyne/cm
Density: 0.976 g/cm3
Flash Point: 326.3 °C
Melting Point: <50 °C
Enthalpy of Vaporization: 91.36 kJ/mol
Boiling Point: 615.9 °C at 760 mmHg
Vapour Pressure: 4.23E-15 mmHg at 25°C
Storage temp: 2-8°C
Solubility: DMSO: 19 mg/mL
Appearance: Off-White Solid
IUPAC Name: [(2S)-1-[(2S,3S)-3-Hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
Synonyms of Orlistat (CAS NO.96829-58-2): (-)-Tetrahydrolipstatin ; Alli ; L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))- ; N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone ; Orlipastat ; Orlipastatum ; Orlipastatum [INN-Latin] ; Ro 18-0647/002 ; Tetrahydrolipstatin ; UNII-95M8R751W8 ; Xenical ; L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester
Product Categories of Orlistat (CAS NO.96829-58-2): Pharmaceutical Raw Materials;Miscellaneous
Biochemicals;API;Antiobesity Agent;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals
Uses
Orlistat (CAS NO.96829-58-2) is a drug designed to treat obesity. It is mainly used for preventing the absorption of fats from the human diet, thereby reducing caloric intake. Besides, it is intended for use in conjunction with a physician-supervised reduced-calorie diet.
Safety Profile
WGK Germany: 3
RTECS: OH3167600
Specification
Side effects of Orlistat (CAS NO.96829-58-2): The primary side effects of the drug are gastrointestinal-related, and include steatorrhea (oily, loose stools with excessive flatus due to unabsorbed fats reaching the large intestine), fecal incontinence and frequent or urgent bowel movements.
-
Premium Related Products
